Electromed Valuation

ELMD Stock  USD 14.50  0.56  4.02%   
At this time, the firm appears to be undervalued. Electromed shows a prevailing Real Value of $17.93 per share. The current price of the firm is $14.5. Our model computes the value of Electromed from reviewing the firm fundamentals such as Profit Margin of 0.08 %, shares outstanding of 8.61 M, and Current Valuation of 109.65 M as well as analyzing its technical indicators and probability of bankruptcy. In general, most investors advise purchasing undervalued instruments and exiting overvalued instruments since, at some point, asset prices and their ongoing real values will submerge. Key fundamental drivers impacting Electromed's valuation include:
Price Book
3.1015
Enterprise Value
109.6 M
Enterprise Value Ebitda
19.7326
Price Sales
2.4204
Trailing PE
32.2222
Undervalued
Today
14.50
Please note that Electromed's price fluctuation is not too volatile at this time. Calculation of the real value of Electromed is based on 3 months time horizon. Increasing Electromed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Electromed is useful when determining the fair value of the Electromed stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Electromed. Since Electromed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Electromed Stock. However, Electromed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  14.5 Real  17.93 Target  26.0 Hype  14.52
The real value of Electromed Stock, also known as its intrinsic value, is the underlying worth of Electromed Company, which is reflected in its stock price. It is based on Electromed's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Electromed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Electromed's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
17.93
Real Value
22.31
Upside
Estimating the potential upside or downside of Electromed helps investors to forecast how Electromed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Electromed more accurately as focusing exclusively on Electromed's fundamentals will not take into account other important factors:
Earnings
Estimates (0)
LowProjectedHigh
0.130.130.13
Details
Hype
Prediction
LowEstimatedHigh
10.1414.5218.90
Details
1 Analysts
Consensus
LowTarget PriceHigh
23.6626.0028.86
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Electromed's intrinsic value based on its ongoing forecasts of Electromed's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Electromed's closest peers. When choosing an evaluation method for Electromed, ensure it is appropriate for the firm given its current financial situation and market classification. If more than one evaluation category is relevant, we suggest using both methods to arrive at a better estimate.

Electromed Investments

(1.62 Million)

Electromed Valuation Trend

Knowing Electromed's actual value is paramount for traders to make sound investment determinations. Electromed's real value is not only important for the investor to make better decisions but also for a more accurate overall view of Electromed's financial worth over time since having this information enables investors and analysts to forecast the earnings more efficiently. Using both Electromed's enterprise value as well as its market capitalization is the best way to gauging the value of the company and is usually enough for investors to make market timing descisions.

Electromed Market Cap

Electromed is rated below average in market capitalization category among related companies. Market capitalization of Health Care industry is currently estimated at about 333.76 Billion. Electromed adds roughly 124.78 Million in market capitalization claiming only tiny portion of equities under Health Care industry.
Capitalization  Revenue  Total debt  Valuation  Workforce

Electromed Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Electromed's current stock value. Our valuation model uses many indicators to compare Electromed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Electromed competition to find correlations between indicators driving Electromed's intrinsic value. More Info.
Electromed is rated below average in price to earning category among related companies. It is rated below average in price to book category among related companies fabricating about  0.13  of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Electromed is roughly  7.63 . As of April 20, 2024, Price To Book Ratio is expected to decline to 2.63. Comparative valuation analysis is a catch-all model that can be used if you cannot value Electromed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Electromed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Electromed's earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Electromed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Electromed and how it compares across the competition.

About Electromed Valuation

The stock valuation mechanism determines the current worth of Electromed on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Electromed. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Electromed based exclusively on its fundamental and basic technical indicators. By analyzing Electromed's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Electromed's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Electromed. We calculate exposure to Electromed's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Electromed's related companies.
Last ReportedProjected for Next Year
Gross Profit42 M44.1 M
Pretax Profit Margin 0.08  0.06 
Operating Profit Margin 0.07  0.06 
Net Profit Margin 0.06  0.04 
Gross Profit Margin 0.68  0.60 

8 Steps to conduct Electromed's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Electromed's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Electromed's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Electromed's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Electromed's revenue streams: Identify Electromed's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Electromed's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Electromed's growth potential: Evaluate Electromed's management, business model, and growth potential.
  • Determine Electromed's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Electromed's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Electromed Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Electromed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding8.7 M
Quarterly Earnings Growth Y O Y0.727

Electromed Current Valuation Indicators

Valuation refers to the process of determining the present value of Electromed and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Electromed we look at many different elements of the entity such as Electromed's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation. Electromed's valuation analysis is also a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Electromed's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Electromed, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Electromed's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Electromed's worth.
When determining whether Electromed is a strong investment it is important to analyze Electromed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Electromed's future performance. For an informed investment choice regarding Electromed Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.
You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Complementary Tools for Electromed Stock analysis

When running Electromed's price analysis, check to measure Electromed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Electromed is operating at the current time. Most of Electromed's value examination focuses on studying past and present price action to predict the probability of Electromed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Electromed's price. Additionally, you may evaluate how the addition of Electromed to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Fundamental Analysis
View fundamental data based on most recent published financial statements
Is Electromed's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.727
Earnings Share
0.45
Revenue Per Share
6.072
Quarterly Revenue Growth
0.167
Return On Assets
0.0721
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.